Additionally, lycopene could alleviate the prostate cancer risk by modulating the growth genes like cyclin-dependent protein kinase 7 (CDK7), B-cell lymphoma 2 (BCL2), epidermal growth factor receptor (EGFR), and insulin-like growth factor 1 (IGF-1) receptor (181). This evidence concerns the gene BCL2 and prostate carcinoma.